Document Detail


Pharmacologic Prophylaxis Regimens for Acute GVHD - Past, Present and Future.
MedLine Citation:
PMID:  23278640     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Abstract Acute graft versus host disease (GVHD) has been, and continues to compromise the benefits associated with allogeneic hematopoietic cell transplantation to cure malignant and non-malignant diseases. Pharmacologic interventions to prevent GVHD have emerged as a major objective of research in the immunology and transplantation fields. A better understanding of the pathobiology behind the GVHD process has led the way to novel approaches and medications. Here we review the present arsenal of medications used to prevent GVHD, focusing on the past experience and the current evidence, and discussing future potential targets.
Authors:
Ron Ram; Rainer Storb
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-1-2
Journal Detail:
Title:  Leukemia & lymphoma     Volume:  -     ISSN:  1029-2403     ISO Abbreviation:  Leuk. Lymphoma     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-1-2     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9007422     Medline TA:  Leuk Lymphoma     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A Multicenter Phase II Trial to Determine the Safety and Efficacy of Combination Therapy With Denile...
Next Document:  Bone Marrow Mast Cell Burden and Serum Tryptase Level as Markers of Response in Patients with System...